nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—SLC22A8—choroid plexus—malignant glioma	0.0726	0.212	CbGeAlD
Furosemide—Cerebration impaired—Temozolomide—malignant glioma	0.0118	0.0292	CcSEcCtD
Furosemide—Thrombosis—Carmustine—malignant glioma	0.0101	0.0251	CcSEcCtD
Furosemide—CA14—telencephalon—malignant glioma	0.0098	0.0287	CbGeAlD
Furosemide—Apathy—Temozolomide—malignant glioma	0.0097	0.024	CcSEcCtD
Furosemide—Flat affect—Temozolomide—malignant glioma	0.00961	0.0238	CcSEcCtD
Furosemide—Cholestasis—Temozolomide—malignant glioma	0.00912	0.0226	CcSEcCtD
Furosemide—SLC12A1—telencephalon—malignant glioma	0.00879	0.0257	CbGeAlD
Furosemide—Injection site pain—Carmustine—malignant glioma	0.00878	0.0218	CcSEcCtD
Furosemide—CA7—midbrain—malignant glioma	0.00845	0.0247	CbGeAlD
Furosemide—Disturbance in attention—Temozolomide—malignant glioma	0.008	0.0198	CcSEcCtD
Furosemide—PGD—retina—malignant glioma	0.00787	0.023	CbGeAlD
Furosemide—Drug interaction—Carmustine—malignant glioma	0.00773	0.0192	CcSEcCtD
Furosemide—CA14—medulla oblongata—malignant glioma	0.0077	0.0225	CbGeAlD
Furosemide—CA12—telencephalon—malignant glioma	0.00764	0.0224	CbGeAlD
Furosemide—Hearing impaired—Temozolomide—malignant glioma	0.00728	0.018	CcSEcCtD
Furosemide—PGD—telencephalon—malignant glioma	0.00723	0.0212	CbGeAlD
Furosemide—CA14—midbrain—malignant glioma	0.00703	0.0206	CbGeAlD
Furosemide—CA14—spinal cord—malignant glioma	0.00686	0.0201	CbGeAlD
Furosemide—CA7—cerebellum—malignant glioma	0.00653	0.0191	CbGeAlD
Furosemide—Aplastic anaemia—Temozolomide—malignant glioma	0.00651	0.0161	CcSEcCtD
Furosemide—Mental disability—Carmustine—malignant glioma	0.00622	0.0154	CcSEcCtD
Furosemide—SLC12A1—spinal cord—malignant glioma	0.00616	0.018	CbGeAlD
Furosemide—CA1—telencephalon—malignant glioma	0.00605	0.0177	CbGeAlD
Furosemide—Mental disability—Temozolomide—malignant glioma	0.00601	0.0149	CcSEcCtD
Furosemide—Thrombophlebitis—Carmustine—malignant glioma	0.00601	0.0149	CcSEcCtD
Furosemide—Diabetes mellitus—Carmustine—malignant glioma	0.00598	0.0148	CcSEcCtD
Furosemide—Swelling—Carmustine—malignant glioma	0.0059	0.0146	CcSEcCtD
Furosemide—Thrombophlebitis—Temozolomide—malignant glioma	0.00581	0.0144	CcSEcCtD
Furosemide—CA9—cerebellum—malignant glioma	0.00574	0.0168	CbGeAlD
Furosemide—PGD—medulla oblongata—malignant glioma	0.00568	0.0166	CbGeAlD
Furosemide—Vascular purpura—Temozolomide—malignant glioma	0.00562	0.0139	CcSEcCtD
Furosemide—Deafness—Temozolomide—malignant glioma	0.00562	0.0139	CcSEcCtD
Furosemide—CA14—cerebellum—malignant glioma	0.00544	0.0159	CbGeAlD
Furosemide—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00533	0.0132	CcSEcCtD
Furosemide—CA4—brainstem—malignant glioma	0.00533	0.0156	CbGeAlD
Furosemide—CA7—brain—malignant glioma	0.00531	0.0155	CbGeAlD
Furosemide—Thirst—Temozolomide—malignant glioma	0.00529	0.0131	CcSEcCtD
Furosemide—Hyponatraemia—Carmustine—malignant glioma	0.00523	0.013	CcSEcCtD
Furosemide—Purpura—Temozolomide—malignant glioma	0.00522	0.0129	CcSEcCtD
Furosemide—PGD—midbrain—malignant glioma	0.0052	0.0152	CbGeAlD
Furosemide—PGD—spinal cord—malignant glioma	0.00507	0.0148	CbGeAlD
Furosemide—SLC12A1—central nervous system—malignant glioma	0.005	0.0146	CbGeAlD
Furosemide—CA2—embryo—malignant glioma	0.00482	0.0141	CbGeAlD
Furosemide—Hypokalaemia—Carmustine—malignant glioma	0.00474	0.0117	CcSEcCtD
Furosemide—CA4—telencephalon—malignant glioma	0.00473	0.0138	CbGeAlD
Furosemide—Dehydration—Temozolomide—malignant glioma	0.00468	0.0116	CcSEcCtD
Furosemide—SLCO2A1—central nervous system—malignant glioma	0.00461	0.0135	CbGeAlD
Furosemide—Muscular weakness—Carmustine—malignant glioma	0.00459	0.0114	CcSEcCtD
Furosemide—Hypokalaemia—Temozolomide—malignant glioma	0.00458	0.0113	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00453	0.0112	CcSEcCtD
Furosemide—Muscular weakness—Temozolomide—malignant glioma	0.00444	0.011	CcSEcCtD
Furosemide—CA14—brain—malignant glioma	0.00442	0.0129	CbGeAlD
Furosemide—CA2—brainstem—malignant glioma	0.00442	0.0129	CbGeAlD
Furosemide—Abdominal distension—Temozolomide—malignant glioma	0.00438	0.0109	CcSEcCtD
Furosemide—CA12—central nervous system—malignant glioma	0.00434	0.0127	CbGeAlD
Furosemide—CA2—retina—malignant glioma	0.00426	0.0125	CbGeAlD
Furosemide—CA1—spinal cord—malignant glioma	0.00424	0.0124	CbGeAlD
Furosemide—SLC22A5—retina—malignant glioma	0.0042	0.0123	CbGeAlD
Furosemide—PGD—central nervous system—malignant glioma	0.00411	0.012	CbGeAlD
Furosemide—Hyperglycaemia—Carmustine—malignant glioma	0.00406	0.0101	CcSEcCtD
Furosemide—PGD—cerebellum—malignant glioma	0.00402	0.0118	CbGeAlD
Furosemide—Pollakiuria—Temozolomide—malignant glioma	0.00402	0.00996	CcSEcCtD
Furosemide—SLC12A1—brain—malignant glioma	0.00397	0.0116	CbGeAlD
Furosemide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00397	0.00984	CcSEcCtD
Furosemide—Renal failure—Carmustine—malignant glioma	0.00394	0.00978	CcSEcCtD
Furosemide—CA2—telencephalon—malignant glioma	0.00392	0.0115	CbGeAlD
Furosemide—Hyperglycaemia—Temozolomide—malignant glioma	0.00392	0.00972	CcSEcCtD
Furosemide—CA5B—central nervous system—malignant glioma	0.0039	0.0114	CbGeAlD
Furosemide—SLC22A6—brain—malignant glioma	0.00385	0.0113	CbGeAlD
Furosemide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00384	0.00953	CcSEcCtD
Furosemide—CA4—medulla oblongata—malignant glioma	0.00372	0.0109	CbGeAlD
Furosemide—Hepatobiliary disease—Temozolomide—malignant glioma	0.00367	0.00909	CcSEcCtD
Furosemide—SLCO2A1—brain—malignant glioma	0.00366	0.0107	CbGeAlD
Furosemide—Visual impairment—Carmustine—malignant glioma	0.00347	0.0086	CcSEcCtD
Furosemide—CA12—brain—malignant glioma	0.00345	0.0101	CbGeAlD
Furosemide—CA1—central nervous system—malignant glioma	0.00344	0.0101	CbGeAlD
Furosemide—Urinary tract disorder—Temozolomide—malignant glioma	0.00344	0.00852	CcSEcCtD
Furosemide—Urethral disorder—Temozolomide—malignant glioma	0.00341	0.00846	CcSEcCtD
Furosemide—CA4—midbrain—malignant glioma	0.0034	0.00994	CbGeAlD
Furosemide—Eye disorder—Carmustine—malignant glioma	0.00337	0.00834	CcSEcCtD
Furosemide—Visual impairment—Temozolomide—malignant glioma	0.00335	0.00831	CcSEcCtD
Furosemide—CA4—spinal cord—malignant glioma	0.00331	0.0097	CbGeAlD
Furosemide—Erythema multiforme—Temozolomide—malignant glioma	0.00329	0.00816	CcSEcCtD
Furosemide—PGD—brain—malignant glioma	0.00326	0.00956	CbGeAlD
Furosemide—Eye disorder—Temozolomide—malignant glioma	0.00325	0.00806	CcSEcCtD
Furosemide—Tinnitus—Temozolomide—malignant glioma	0.00324	0.00804	CcSEcCtD
Furosemide—Arrhythmia—Carmustine—malignant glioma	0.00322	0.00797	CcSEcCtD
Furosemide—Angiopathy—Temozolomide—malignant glioma	0.00316	0.00783	CcSEcCtD
Furosemide—Immune system disorder—Temozolomide—malignant glioma	0.00314	0.00779	CcSEcCtD
Furosemide—Malnutrition—Carmustine—malignant glioma	0.00313	0.00777	CcSEcCtD
Furosemide—Erythema—Carmustine—malignant glioma	0.00313	0.00777	CcSEcCtD
Furosemide—CA5B—brain—malignant glioma	0.00309	0.00905	CbGeAlD
Furosemide—CA2—medulla oblongata—malignant glioma	0.00308	0.00902	CbGeAlD
Furosemide—SLC22A5—medulla oblongata—malignant glioma	0.00303	0.00888	CbGeAlD
Furosemide—Erythema—Temozolomide—malignant glioma	0.00303	0.00751	CcSEcCtD
Furosemide—Malnutrition—Temozolomide—malignant glioma	0.00303	0.00751	CcSEcCtD
Furosemide—Dysgeusia—Temozolomide—malignant glioma	0.00297	0.00735	CcSEcCtD
Furosemide—Vision blurred—Carmustine—malignant glioma	0.00295	0.00732	CcSEcCtD
Furosemide—SLC22A8—central nervous system—malignant glioma	0.0029	0.00849	CbGeAlD
Furosemide—Anaemia—Carmustine—malignant glioma	0.0029	0.00718	CcSEcCtD
Furosemide—Agitation—Carmustine—malignant glioma	0.00288	0.00714	CcSEcCtD
Furosemide—Vision blurred—Temozolomide—malignant glioma	0.00285	0.00708	CcSEcCtD
Furosemide—CA2—midbrain—malignant glioma	0.00282	0.00825	CbGeAlD
Furosemide—Leukopenia—Carmustine—malignant glioma	0.00281	0.00696	CcSEcCtD
Furosemide—Anaemia—Temozolomide—malignant glioma	0.0028	0.00694	CcSEcCtD
Furosemide—Agitation—Temozolomide—malignant glioma	0.00278	0.0069	CcSEcCtD
Furosemide—SLC22A5—midbrain—malignant glioma	0.00277	0.00811	CbGeAlD
Furosemide—CA2—spinal cord—malignant glioma	0.00275	0.00804	CbGeAlD
Furosemide—CA1—brain—malignant glioma	0.00273	0.00799	CbGeAlD
Furosemide—Vertigo—Temozolomide—malignant glioma	0.00272	0.00675	CcSEcCtD
Furosemide—Leukopenia—Temozolomide—malignant glioma	0.00271	0.00672	CcSEcCtD
Furosemide—SLC22A5—spinal cord—malignant glioma	0.0027	0.00791	CbGeAlD
Furosemide—CA4—central nervous system—malignant glioma	0.00269	0.00787	CbGeAlD
Furosemide—CA4—cerebellum—malignant glioma	0.00263	0.00769	CbGeAlD
Furosemide—Confusional state—Carmustine—malignant glioma	0.00258	0.00639	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00256	0.00635	CcSEcCtD
Furosemide—Dry mouth—Temozolomide—malignant glioma	0.00252	0.00625	CcSEcCtD
Furosemide—Thrombocytopenia—Carmustine—malignant glioma	0.0025	0.00621	CcSEcCtD
Furosemide—Confusional state—Temozolomide—malignant glioma	0.00249	0.00618	CcSEcCtD
Furosemide—Anaphylactic shock—Temozolomide—malignant glioma	0.00247	0.00613	CcSEcCtD
Furosemide—Anorexia—Carmustine—malignant glioma	0.00244	0.00605	CcSEcCtD
Furosemide—Nervous system disorder—Temozolomide—malignant glioma	0.00242	0.00601	CcSEcCtD
Furosemide—Thrombocytopenia—Temozolomide—malignant glioma	0.00242	0.006	CcSEcCtD
Furosemide—Skin disorder—Temozolomide—malignant glioma	0.0024	0.00595	CcSEcCtD
Furosemide—ALB—brain—malignant glioma	0.0024	0.00702	CbGeAlD
Furosemide—Hypotension—Carmustine—malignant glioma	0.00239	0.00593	CcSEcCtD
Furosemide—Hyperhidrosis—Temozolomide—malignant glioma	0.00239	0.00593	CcSEcCtD
Furosemide—Anorexia—Temozolomide—malignant glioma	0.00236	0.00584	CcSEcCtD
Furosemide—SLC22A8—brain—malignant glioma	0.0023	0.00674	CbGeAlD
Furosemide—Paraesthesia—Carmustine—malignant glioma	0.0023	0.00569	CcSEcCtD
Furosemide—Somnolence—Carmustine—malignant glioma	0.00227	0.00564	CcSEcCtD
Furosemide—CA2—central nervous system—malignant glioma	0.00223	0.00653	CbGeAlD
Furosemide—Decreased appetite—Carmustine—malignant glioma	0.00222	0.00551	CcSEcCtD
Furosemide—Paraesthesia—Temozolomide—malignant glioma	0.00222	0.0055	CcSEcCtD
Furosemide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00221	0.00548	CcSEcCtD
Furosemide—Somnolence—Temozolomide—malignant glioma	0.0022	0.00545	CcSEcCtD
Furosemide—Constipation—Carmustine—malignant glioma	0.00219	0.00542	CcSEcCtD
Furosemide—Pain—Carmustine—malignant glioma	0.00219	0.00542	CcSEcCtD
Furosemide—CA2—cerebellum—malignant glioma	0.00218	0.00638	CbGeAlD
Furosemide—Decreased appetite—Temozolomide—malignant glioma	0.00215	0.00533	CcSEcCtD
Furosemide—SLC22A5—cerebellum—malignant glioma	0.00214	0.00628	CbGeAlD
Furosemide—CA4—brain—malignant glioma	0.00213	0.00625	CbGeAlD
Furosemide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00213	0.00529	CcSEcCtD
Furosemide—Fatigue—Temozolomide—malignant glioma	0.00213	0.00528	CcSEcCtD
Furosemide—Pain—Temozolomide—malignant glioma	0.00211	0.00524	CcSEcCtD
Furosemide—Constipation—Temozolomide—malignant glioma	0.00211	0.00524	CcSEcCtD
Furosemide—Feeling abnormal—Carmustine—malignant glioma	0.00211	0.00523	CcSEcCtD
Furosemide—Gastrointestinal pain—Carmustine—malignant glioma	0.00209	0.00519	CcSEcCtD
Furosemide—Feeling abnormal—Temozolomide—malignant glioma	0.00204	0.00505	CcSEcCtD
Furosemide—Abdominal pain—Carmustine—malignant glioma	0.00202	0.00501	CcSEcCtD
Furosemide—Body temperature increased—Carmustine—malignant glioma	0.00202	0.00501	CcSEcCtD
Furosemide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00202	0.00501	CcSEcCtD
Furosemide—Urticaria—Temozolomide—malignant glioma	0.00196	0.00487	CcSEcCtD
Furosemide—Abdominal pain—Temozolomide—malignant glioma	0.00195	0.00485	CcSEcCtD
Furosemide—Body temperature increased—Temozolomide—malignant glioma	0.00195	0.00485	CcSEcCtD
Furosemide—Hypersensitivity—Carmustine—malignant glioma	0.00188	0.00467	CcSEcCtD
Furosemide—Asthenia—Carmustine—malignant glioma	0.00184	0.00455	CcSEcCtD
Furosemide—Hypersensitivity—Temozolomide—malignant glioma	0.00182	0.00452	CcSEcCtD
Furosemide—Asthenia—Temozolomide—malignant glioma	0.00177	0.0044	CcSEcCtD
Furosemide—CA2—brain—malignant glioma	0.00177	0.00518	CbGeAlD
Furosemide—Diarrhoea—Carmustine—malignant glioma	0.00175	0.00434	CcSEcCtD
Furosemide—Pruritus—Temozolomide—malignant glioma	0.00175	0.00434	CcSEcCtD
Furosemide—SLC22A5—brain—malignant glioma	0.00174	0.0051	CbGeAlD
Furosemide—Dizziness—Carmustine—malignant glioma	0.00169	0.00419	CcSEcCtD
Furosemide—Diarrhoea—Temozolomide—malignant glioma	0.00169	0.00419	CcSEcCtD
Furosemide—Dizziness—Temozolomide—malignant glioma	0.00163	0.00405	CcSEcCtD
Furosemide—Vomiting—Carmustine—malignant glioma	0.00163	0.00403	CcSEcCtD
Furosemide—Rash—Carmustine—malignant glioma	0.00161	0.004	CcSEcCtD
Furosemide—Dermatitis—Carmustine—malignant glioma	0.00161	0.004	CcSEcCtD
Furosemide—Headache—Carmustine—malignant glioma	0.0016	0.00397	CcSEcCtD
Furosemide—Vomiting—Temozolomide—malignant glioma	0.00157	0.0039	CcSEcCtD
Furosemide—Rash—Temozolomide—malignant glioma	0.00156	0.00386	CcSEcCtD
Furosemide—Dermatitis—Temozolomide—malignant glioma	0.00156	0.00386	CcSEcCtD
Furosemide—Headache—Temozolomide—malignant glioma	0.00155	0.00384	CcSEcCtD
Furosemide—Nausea—Carmustine—malignant glioma	0.00152	0.00377	CcSEcCtD
Furosemide—Nausea—Temozolomide—malignant glioma	0.00147	0.00364	CcSEcCtD
Furosemide—PGD—Metabolism—NCOR1—malignant glioma	0.000193	0.000757	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000193	0.000756	CbGpPWpGaD
Furosemide—CA4—Metabolism—BCHE—malignant glioma	0.000189	0.00074	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSTP1—malignant glioma	0.000188	0.000738	CbGpPWpGaD
Furosemide—PGD—Disease—CAV1—malignant glioma	0.000188	0.000736	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000188	0.000736	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000187	0.000733	CbGpPWpGaD
Furosemide—ALB—Hemostasis—ANGPT2—malignant glioma	0.000187	0.000732	CbGpPWpGaD
Furosemide—CA7—Metabolism—NCOR1—malignant glioma	0.000187	0.000732	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NCOR1—malignant glioma	0.000187	0.000732	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS1—malignant glioma	0.000187	0.000731	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC5A5—malignant glioma	0.000186	0.000731	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000185	0.000727	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000184	0.00072	CbGpPWpGaD
Furosemide—CA12—Metabolism—CAT—malignant glioma	0.000183	0.000718	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	0.000182	0.000715	CbGpPWpGaD
Furosemide—CA2—Metabolism—BCHE—malignant glioma	0.000181	0.000709	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC5A5—malignant glioma	0.000179	0.000701	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000178	0.000697	CbGpPWpGaD
Furosemide—PGD—Disease—BAD—malignant glioma	0.000177	0.000693	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTT1—malignant glioma	0.000175	0.000686	CbGpPWpGaD
Furosemide—PGD—Disease—NOTCH1—malignant glioma	0.000175	0.000686	CbGpPWpGaD
Furosemide—CA1—Metabolism—BCHE—malignant glioma	0.000173	0.00068	CbGpPWpGaD
Furosemide—CA12—Metabolism—NCOR1—malignant glioma	0.000173	0.000678	CbGpPWpGaD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000171	0.000672	CbGpPWpGaD
Furosemide—PGD—Disease—CD80—malignant glioma	0.000171	0.000672	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC5A5—malignant glioma	0.000171	0.000672	CbGpPWpGaD
Furosemide—PGD—Disease—APC—malignant glioma	0.000171	0.000671	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.00017	0.000668	CbGpPWpGaD
Furosemide—PGD—Disease—EGF—malignant glioma	0.000169	0.000663	CbGpPWpGaD
Furosemide—PGD—Disease—PTPN11—malignant glioma	0.000168	0.000659	CbGpPWpGaD
Furosemide—CA14—Metabolism—CAV1—malignant glioma	0.000167	0.000656	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—malignant glioma	0.000166	0.000653	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—malignant glioma	0.000166	0.000653	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS1—malignant glioma	0.000164	0.000643	CbGpPWpGaD
Furosemide—CA6—Metabolism—CAV1—malignant glioma	0.000163	0.000639	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CAV1—malignant glioma	0.000163	0.000639	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HIST1H3B—malignant glioma	0.000162	0.000634	CbGpPWpGaD
Furosemide—PGD—Disease—BRAF—malignant glioma	0.000161	0.000631	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MYB—malignant glioma	0.00016	0.000628	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00016	0.000627	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000159	0.000622	CbGpPWpGaD
Furosemide—PGD—Metabolism—CAV1—malignant glioma	0.000157	0.000617	CbGpPWpGaD
Furosemide—PGD—Disease—AKT2—malignant glioma	0.000157	0.000614	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—malignant glioma	0.000155	0.000609	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000155	0.000606	CbGpPWpGaD
Furosemide—CA9—Metabolism—BCHE—malignant glioma	0.000152	0.000598	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CG—malignant glioma	0.000152	0.000598	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CAV1—malignant glioma	0.000152	0.000597	CbGpPWpGaD
Furosemide—CA7—Metabolism—CAV1—malignant glioma	0.000152	0.000597	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC5A5—malignant glioma	0.000151	0.00059	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CD—malignant glioma	0.00015	0.00059	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTP1—malignant glioma	0.00015	0.000589	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CG—malignant glioma	0.000148	0.000582	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CG—malignant glioma	0.000148	0.000582	CbGpPWpGaD
Furosemide—CA14—Metabolism—PPARG—malignant glioma	0.000147	0.000577	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—malignant glioma	0.000147	0.000575	CbGpPWpGaD
Furosemide—CA4—Metabolism—CAT—malignant glioma	0.000146	0.000573	CbGpPWpGaD
Furosemide—PGD—Disease—FGF2—malignant glioma	0.000144	0.000565	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTP1—malignant glioma	0.000144	0.000564	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PPARG—malignant glioma	0.000143	0.000562	CbGpPWpGaD
Furosemide—CA6—Metabolism—PPARG—malignant glioma	0.000143	0.000562	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CG—malignant glioma	0.000143	0.000562	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000143	0.000561	CbGpPWpGaD
Furosemide—CA12—Metabolism—CAV1—malignant glioma	0.000141	0.000553	CbGpPWpGaD
Furosemide—CA2—Metabolism—CAT—malignant glioma	0.00014	0.000549	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CG—malignant glioma	0.000139	0.000544	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CG—malignant glioma	0.000139	0.000544	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPARG—malignant glioma	0.000138	0.000542	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTP1—malignant glioma	0.000138	0.000541	CbGpPWpGaD
Furosemide—CA4—Metabolism—NCOR1—malignant glioma	0.000138	0.000541	CbGpPWpGaD
Furosemide—PGD—Disease—MDM2—malignant glioma	0.000135	0.000528	CbGpPWpGaD
Furosemide—PGD—Disease—RAF1—malignant glioma	0.000134	0.000526	CbGpPWpGaD
Furosemide—CA1—Metabolism—CAT—malignant glioma	0.000134	0.000526	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CD—malignant glioma	0.000134	0.000525	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPARG—malignant glioma	0.000134	0.000525	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPARG—malignant glioma	0.000134	0.000525	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB2—malignant glioma	0.000133	0.000521	CbGpPWpGaD
Furosemide—CA2—Metabolism—NCOR1—malignant glioma	0.000132	0.000519	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000132	0.000519	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CB—malignant glioma	0.000131	0.000514	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000131	0.000513	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CD—malignant glioma	0.000131	0.000512	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CD—malignant glioma	0.000131	0.000512	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—malignant glioma	0.00013	0.000509	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000129	0.000506	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000129	0.000506	CbGpPWpGaD
Furosemide—ALB—Metabolism—COX8A—malignant glioma	0.000128	0.000504	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CG—malignant glioma	0.000128	0.000504	CbGpPWpGaD
Furosemide—CA1—Metabolism—NCOR1—malignant glioma	0.000127	0.000497	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CD—malignant glioma	0.000126	0.000494	CbGpPWpGaD
Furosemide—ALB—Hemostasis—H3F3A—malignant glioma	0.000125	0.00049	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARG—malignant glioma	0.000124	0.000486	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000123	0.000484	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000122	0.000479	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CD—malignant glioma	0.000122	0.000478	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CD—malignant glioma	0.000122	0.000478	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTP1—malignant glioma	0.000121	0.000476	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAT—malignant glioma	0.000118	0.000463	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CB—malignant glioma	0.000117	0.000458	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—malignant glioma	0.000116	0.000454	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000115	0.00045	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CB—malignant glioma	0.000114	0.000446	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CB—malignant glioma	0.000114	0.000446	CbGpPWpGaD
Furosemide—PGD—Disease—PTEN—malignant glioma	0.000113	0.000444	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000113	0.000443	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CD—malignant glioma	0.000113	0.000443	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—malignant glioma	0.000113	0.000442	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—malignant glioma	0.000113	0.000442	CbGpPWpGaD
Furosemide—CA4—Metabolism—CAV1—malignant glioma	0.000112	0.000441	CbGpPWpGaD
Furosemide—CA9—Metabolism—NCOR1—malignant glioma	0.000111	0.000437	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	0.00011	0.000432	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CB—malignant glioma	0.00011	0.00043	CbGpPWpGaD
Furosemide—ALB—Metabolism—ASMT—malignant glioma	0.000109	0.000428	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000109	0.000428	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—malignant glioma	0.000109	0.000427	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000109	0.000426	CbGpPWpGaD
Furosemide—CA2—Metabolism—CAV1—malignant glioma	0.000108	0.000423	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000107	0.000419	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CB—malignant glioma	0.000106	0.000417	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CB—malignant glioma	0.000106	0.000417	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—malignant glioma	0.000105	0.000413	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—malignant glioma	0.000105	0.000413	CbGpPWpGaD
Furosemide—CA1—Metabolism—CAV1—malignant glioma	0.000103	0.000405	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KNG1—malignant glioma	0.000103	0.000404	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCAN—malignant glioma	0.000103	0.000403	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CG—malignant glioma	0.000102	0.000402	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—malignant glioma	0.000101	0.000397	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTEN—malignant glioma	0.000101	0.000396	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IFNA2—malignant glioma	0.000101	0.000395	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.0001	0.000393	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	9.97e-05	0.000391	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—malignant glioma	9.88e-05	0.000388	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CB—malignant glioma	9.84e-05	0.000386	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTEN—malignant glioma	9.83e-05	0.000386	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTEN—malignant glioma	9.83e-05	0.000386	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CG—malignant glioma	9.82e-05	0.000385	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—malignant glioma	9.75e-05	0.000382	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	9.69e-05	0.00038	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SOD1—malignant glioma	9.56e-05	0.000375	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.54e-05	0.000374	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTEN—malignant glioma	9.49e-05	0.000372	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—malignant glioma	9.48e-05	0.000372	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	9.46e-05	0.000371	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CG—malignant glioma	9.41e-05	0.000369	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—malignant glioma	9.41e-05	0.000369	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—malignant glioma	9.21e-05	0.000361	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTEN—malignant glioma	9.18e-05	0.00036	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTEN—malignant glioma	9.18e-05	0.00036	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAV1—malignant glioma	9.09e-05	0.000356	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—malignant glioma	9.09e-05	0.000356	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CD—malignant glioma	9e-05	0.000353	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PTK2—malignant glioma	8.78e-05	0.000344	CbGpPWpGaD
Furosemide—PGD—Disease—KRAS—malignant glioma	8.7e-05	0.000341	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	8.69e-05	0.000341	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CD—malignant glioma	8.63e-05	0.000338	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTEN—malignant glioma	8.5e-05	0.000333	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	8.32e-05	0.000326	CbGpPWpGaD
Furosemide—ALB—Metabolism—IDH2—malignant glioma	8.28e-05	0.000325	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CG—malignant glioma	8.28e-05	0.000325	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CD—malignant glioma	8.28e-05	0.000325	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	8.06e-05	0.000316	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—malignant glioma	7.99e-05	0.000313	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—malignant glioma	7.99e-05	0.000313	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CB—malignant glioma	7.85e-05	0.000308	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.8e-05	0.000306	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2B6—malignant glioma	7.78e-05	0.000305	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—malignant glioma	7.78e-05	0.000305	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CB—malignant glioma	7.52e-05	0.000295	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—malignant glioma	7.45e-05	0.000292	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	7.39e-05	0.00029	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PDGFB—malignant glioma	7.37e-05	0.000289	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CD—malignant glioma	7.28e-05	0.000285	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CB—malignant glioma	7.21e-05	0.000283	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—malignant glioma	7.15e-05	0.00028	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—malignant glioma	7.12e-05	0.000279	CbGpPWpGaD
Furosemide—ALB—Metabolism—IDH1—malignant glioma	7.12e-05	0.000279	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CAV1—malignant glioma	6.99e-05	0.000274	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—malignant glioma	6.94e-05	0.000272	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—malignant glioma	6.94e-05	0.000272	CbGpPWpGaD
Furosemide—ALB—Metabolism—SPHK1—malignant glioma	6.89e-05	0.00027	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTEN—malignant glioma	6.78e-05	0.000266	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2C18—malignant glioma	6.75e-05	0.000265	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—malignant glioma	6.69e-05	0.000262	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F2—malignant glioma	6.65e-05	0.000261	CbGpPWpGaD
Furosemide—ALB—Hemostasis—FN1—malignant glioma	6.65e-05	0.000261	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—malignant glioma	6.53e-05	0.000256	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTEN—malignant glioma	6.5e-05	0.000255	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—malignant glioma	6.48e-05	0.000254	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—malignant glioma	6.48e-05	0.000254	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CG—malignant glioma	6.37e-05	0.00025	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.36e-05	0.000249	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CB—malignant glioma	6.34e-05	0.000249	CbGpPWpGaD
Furosemide—ALB—Hemostasis—EGF—malignant glioma	6.29e-05	0.000247	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—malignant glioma	6.28e-05	0.000246	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PTPN11—malignant glioma	6.25e-05	0.000245	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTEN—malignant glioma	6.23e-05	0.000244	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—malignant glioma	6e-05	0.000235	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT2—malignant glioma	5.82e-05	0.000228	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—malignant glioma	5.81e-05	0.000228	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.8e-05	0.000227	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	5.77e-05	0.000226	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—malignant glioma	5.67e-05	0.000222	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—malignant glioma	5.67e-05	0.000222	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CD—malignant glioma	5.6e-05	0.000219	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.59e-05	0.000219	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTEN—malignant glioma	5.48e-05	0.000215	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—malignant glioma	5.47e-05	0.000214	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTT1—malignant glioma	5.46e-05	0.000214	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—malignant glioma	5.29e-05	0.000207	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—malignant glioma	5.29e-05	0.000207	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS1—malignant glioma	5.11e-05	0.000201	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.09e-05	0.0002	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAF1—malignant glioma	5e-05	0.000196	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—malignant glioma	4.9e-05	0.000192	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CB—malignant glioma	4.88e-05	0.000191	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—malignant glioma	4.78e-05	0.000188	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCHE—malignant glioma	4.75e-05	0.000186	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	4.71e-05	0.000185	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC5A5—malignant glioma	4.7e-05	0.000184	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—malignant glioma	4.59e-05	0.00018	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IL2—malignant glioma	4.48e-05	0.000176	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.44e-05	0.000174	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.4e-05	0.000173	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—malignant glioma	4.4e-05	0.000172	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	4.32e-05	0.00017	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—malignant glioma	3.91e-05	0.000153	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—malignant glioma	3.87e-05	0.000152	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.84e-05	0.00015	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—malignant glioma	3.81e-05	0.000149	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTP1—malignant glioma	3.78e-05	0.000148	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—malignant glioma	3.75e-05	0.000147	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAT—malignant glioma	3.68e-05	0.000144	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—malignant glioma	3.59e-05	0.000141	CbGpPWpGaD
Furosemide—ALB—Metabolism—NCOR1—malignant glioma	3.48e-05	0.000136	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KRAS—malignant glioma	3.24e-05	0.000127	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—malignant glioma	3.16e-05	0.000124	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—malignant glioma	2.97e-05	0.000117	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—malignant glioma	2.88e-05	0.000113	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAV1—malignant glioma	2.83e-05	0.000111	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.71e-05	0.000106	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CG—malignant glioma	2.58e-05	0.000101	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—malignant glioma	2.49e-05	9.77e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—malignant glioma	2.43e-05	9.53e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CD—malignant glioma	2.27e-05	8.9e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CB—malignant glioma	1.98e-05	7.75e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—malignant glioma	1.96e-05	7.68e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTEN—malignant glioma	1.71e-05	6.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—malignant glioma	1.21e-05	4.73e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—malignant glioma	9.85e-06	3.86e-05	CbGpPWpGaD
